As Barostim™ therapy adoption expands, programs are increasingly expected to demonstrate objective patient outcomes in ways that are consistent, reproducible and meaningful to clinicians and administrators. A new CV business white paper shares the real-world Barostim experience of a nonprofit, community-directed health system that developed a pragmatic, operations-focused framework for selecting, collecting and using baseline and long-term metrics to assess patient response to Barostim therapy. The paper presents a viable metrics framework that can be implemented early, adopted locally, and scaled over time. 

ACCESS CV BUSINESS WHITE PAPER